Expression of the human cancer/testis antigen NY-SAR-35 is activated by CpG island hypomethylation

Biotechnology Letters

Volumn 33, Issue 6, 2011, Pages 1085-1091

  Park, Jin Hyung ^a   Song, Myung Ha ^a   Lee, Chang Hun ^a   Lee, Min Ki ^b   Park, Young Min ^a   Old, Lloyd ^c   Lee, Sang Yull ^a  

^a Pusan National University School of Medicine   (South Korea)

^b Pusan National University Hospital   (South Korea)

^c MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Antigen gene (NY SAR 35); Cancer testis (CT) antigen; Gene expression; Methylation; NY SAR 35

Indexed keywords

ANTIGEN GENES; CANCER CELL LINES; CANCER/TESTIS (CT) ANTIGEN; CPG ISLANDS; GENE PROMOTER; HISTOLOGICAL TYPE; HUMAN CANCER; HUMAN CANCER CELLS; HYPOMETHYLATION; IN-VITRO; NY-SAR-35; PROMOTER ACTIVITIES; PROMOTER REGION;

ALKYLATION; ANTIGENS; CELL CULTURE; CELLS; DISEASES; METHYLATION; TISSUE;

GENE EXPRESSION;

5 AZA 2' DEOXYCYTIDINE; AZACITIDINE; DRUG DERIVATIVE; NY SAR 35 ANTIGEN, HUMAN; NY-SAR-35 ANTIGEN, HUMAN; PRIMER DNA; RNA; TUMOR ANTIGEN;

ARTICLE; BIOTECHNOLOGY; CPG ISLAND; DNA METHYLATION; DRUG EFFECT; FEMALE; GENE EXPRESSION; GENETIC TRANSFECTION; GENETICS; HUMAN; IMMUNOLOGY; MALE; MOLECULAR CLONING; NUCLEOTIDE SEQUENCE; PROMOTER REGION; TESTIS; TUMOR CELL LINE;

ANTIGENS, NEOPLASM; AZACITIDINE; BASE SEQUENCE; BIOTECHNOLOGY; CELL LINE, TUMOR; CLONING, MOLECULAR; CPG ISLANDS; DNA METHYLATION; DNA PRIMERS; FEMALE; GENE EXPRESSION; HUMANS; MALE; PROMOTER REGIONS, GENETIC; RNA, NEOPLASM; TESTIS; TRANSFECTION;

EID: 79955930419     PISSN: 01415492     EISSN: 15736776     Source Type: Journal    
DOI: 10.1007/s10529-011-0559-y     Document Type: Article

References (15)

1. Adair SJ, Hogan KT (2009) Treatment of ovarian cancer cell lines with 5-aza-2′-deoxycytidine upregulates the expression of cancer-testis antigens and class I major histocompatibility complex-encoded molecules. Cancer Immunol Immunother 58: 589-601.
2. Caballero OL, Chen YT (2009) Cancer/testis (CT) antigens: potential targets for immunotherapy. Cancer Sci 100: 2014-2021.
3. Chatterjee M, Mohapatra S, Ionan A, Bawa G, Ali-Fehmi R, Wang X, Nowak J, Ye B, Nahhas FA, Lu K, Witkin SS, Fishman D, Munkarah A, Morris R, Levin NK, Shirley NN, Tromp G, Abrams J, Draghici S, Tainsky MA (2006) Diagnostic markers of ovarian cancer by high-throughput antigen cloning and detection on arrays. Cancer Res 66: 1181-1190.
4. Chen YT, Scanlan MJ, Sahin U, Tureci O, Gure AO, Tsang S, Williamson B, Stockert E, Pfreundschuh M, Old LJ (1997) A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening. Proc Natl Acad Sci USA 94: 1914-1918.
5. Colella S, Shen L, Baggerly KA, Issa JP, Krahe R (2003) Sensitive and quantitative universal pyrosequencing methylation analysis of CpG sites. Biotechniques 35: 146-150.
6. Dubovsky JA, McNeel DG (2007) Inducible expression of a prostate cancer-testis antigen, SSX-2, following treatment with a DNA methylation inhibitor. Prostate 67: 1781-1790.
7. Herman JG, Graff JR, Myohanen S, Nelkin BD, Baylin SB (1996) Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA 93: 9821-9826.
8. Lee SY, Obata Y, Yoshida M, Stockert E, Williamson B, Jungbluth AA, Chen YT, Old LJ, Scanlan MJ (2003) Immunomic analysis of human sarcoma. Proc Natl Acad Sci USA 100: 2651-2656.
9. Lim JH, Kim SP, Gabrielson E, Park YB, Park JW, Kwon TK (2005) Activation of human cancer/testis antigen gene, XAGE-1, in tumor cells is correlated with CpG island hypomethylation. Int J Cancer 116: 200-206.
10. Oi S, Natsume A, Ito M, Kondo Y, Shimato S, Maeda Y, Saito K, Wakabayashi T (2009) Synergistic induction of NY-ESO-1 antigen expression by a novel histone deacetylase inhibitor, valproic acid, with 5-aza-2′-deoxycytidine in glioma cells. J Neurooncol 92: 15-22.
11. Scanlan MJ, Gure AO, Jungbluth AA, Old LJ, Chen YT (2002) Cancer/testis antigens: an expanding family of targets for cancer immunotherapy. Immunol Rev 188: 22-32.
12. Sigalotti L, Fratta E, Coral S, Tanzarella S, Danielli R, Colizzi F, Fonsatti E, Traversari C, Altomonte M, Maio M (2004) Intratumor heterogeneity of cancer/testis antigens expression in human cutaneous melanoma is methylation-regulated and functionally reverted by 5-aza-2′-deoxycytidine. Cancer Res 64: 9167-9171.
13. Simpson AJ, Caballero OL, Jungbluth A, Chen YT, Old LJ (2005) Cancer/testis antigens, gametogenesis and cancer. Nat Rev Cancer 5: 615-625.
14. Struhl K (1998) Histone acetylation and transcriptional regulatory mechanisms. Genes Dev 12: 599-606.
15. van der Bruggen P, Traversari C, Chomez P, Lurquin C, De Plaen E, van den Eynde B, Knuth A, Boon T (1991) A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science 254: 1643-1647.